gms | German Medical Science

21st Annual Meeting of the German Retina Society and 8th Symposium of the International Society of Ocular Trauma (ISOT)

German Retina Society
International Society of Ocular Trauma

19.06. - 22.06.2008, Würzburg

„Bonner record form” – documentation of all relevant parameters during Anti-VEGF-therapy

Meeting Abstract

Search Medline for

  • Carsten H. Meyer - Bonn/Germany
  • F.G. Holz - Bonn/Germany

Retinologische Gesellschaft. International Society of Ocular Trauma. 21. Jahrestagung der Retinologischen Gesellschaft gemeinsam mit dem 8. Symposium der International Society of Ocular Trauma. Würzburg, 19.-22.06.2008. Düsseldorf: German Medical Science GMS Publishing House; 2008. DocISOTRG2008P10

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/rg2008/08rg152.shtml

Published: June 18, 2008

© 2008 Meyer et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: Intravitreal injections have become the most frequent treatment approach for vascular retinal disease. The main important clinical features of the fluorescein angiography (FA), optical coherence tomography (OCT), fundus examination and best corrected visual acuity (BCVA) are commonly documented in a non-structured manor during base line examination as well as repeated follow-up examinations.

Methods: We designed a novel patient record form including the essential values of each visit. The top of the page contains the personal dates including name of the patient, date of birth,referring physician, insurance company, (OD/OS), type of disease as well as chosen anti-VEGF agent. Below, there is a table containing a column for each visit to document the subjective VA of the patient the obtained BCVA, the central retinal thickness as well as a description of the tomographic feature, type of CNV, amount of leakage. Disease progression e.g. hemorrhages, RPE-tears are also recorded at each visit. The final line gives space for further recommendations: next follow-up appointment, next treatment date or delay by the involved insurance company.

Results: The novel Bonner patients\'27 record is an excellent tool to document the results of repeated uniform examinations. A study of a conventional patient chart takes several minutes to generate the essential information regarding the initial and latest key features on numerous pages and sheets. However, our patient record form highlights the essential values at each follow-up visit. In addition gives a graphic chart an immediate overview of the funcional and anatomical status. The compact overview helps to make a solid decision for or against another intravitreal injection in a well-organized manor.

Conclusion: We designed for anti-VEGF-patients a structured record form similar to well-established graphic charts for glaucoma patients. The Bonner patients\'27 record form is a valuable tool to document the key features of a stringent algorithm at each visit.